Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$1.04 -0.04 (-3.70%)
At close: Sep 9, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Other Working Capital Changes (2022 - 2025)

Creative Medical Technology Holdings' (CELZ) quarterly Other Working Capital Changes came in at -$34572.0 in Q2 2026, up 34.22% year-over-year from -$25757.7 in Q2 2025, and down 2.37% quarter-over-quarter from -$33772.0 in Q1 2026.

Analysis

Creative Medical Technology Holdings (CELZ) Other Working Capital Changes (2022 - 2025) Analysis & Trends

Creative Medical Technology Holdings (CELZ) has reported Other Working Capital Changes for 3 consecutive years, with -$34572.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Working Capital Changes rose 34.22% year-over-year to -$34572.0 in Q2 2026; TTM through Jun 2026 was -$173458.0, a 331.98% decrease from a year earlier, with the FY2025 full-year figure at -$53903.0, up 36.24% from the prior year.
  • Other Working Capital Changes was -$52557.0 for Q3 2025 at Creative Medical Technology Holdings, roughly flat from -$52557.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $92214.0 in Q1 2023 and troughed at -$86682.0 in Q1 2024.
  • A 4-year average of -$8242.5 and a median of -$52557.0 in 2025 frame the typical range for Other Working Capital Changes.
  • The widest YoY moves for Other Working Capital Changes: up 35.74% in 2026, down 34.22% in 2026.
  • Over 4 years, Other Working Capital Changes stood at -$64960.0 in 2022, then soared by 241.96% to $92214.0 in 2023, then sank by 166.67% to -$61478.0 in 2024, then advanced by 14.51% to -$52557.0 in 2025.
  • The last three Other Working Capital Changes figures came in at -$52557.0 (Q3 2025), -$52557.0 (Q2 2025), and -$52557.0 (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.60 Bn 9.76 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.39 Bn 5.39 Bn -
3 Iovance Biotherapeutics 3.98 Bn 3.68 Bn 55.72 Mn
4 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn
5 uniQure 3.09 Bn 3.09 Bn 5.49 Mn
6 Beam Therapeutics 3.06 Bn 3.06 Bn -
7 Precigen 2.54 Bn 2.54 Bn 52.17 Mn
8 Sarepta Therapeutics 2.38 Bn 1.58 Bn 251.87 Mn
9 Vericel 2.06 Bn 1.89 Bn 56.40 Mn
10 Creative Medical Technology Holdings 1.48 Mn 1.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -52,557.00
Sep 30, 2025 -52,557.00
Jun 30, 2025 -52,557.00
Jun 30, 2025 -52,557.00
Mar 31, 2025 -52,557.00
Mar 31, 2025 -52,557.00
Sep 30, 2024 -61,478.00
Sep 30, 2024 -61,478.00
Jun 30, 2024 -61,478.00
Jun 30, 2024 -61,478.00
Mar 31, 2024 -86,682.00
Mar 31, 2024 -86,682.00
Sep 30, 2023 92,214.00
Sep 30, 2023 92,214.00
Jun 30, 2023 92,214.00
Jun 30, 2023 92,214.00
Mar 31, 2023 92,214.00
Mar 31, 2023 92,214.00
Sep 30, 2022 -64,960.00
Sep 30, 2022 -64,960.00